JP2021515789A5 - - Google Patents

Info

Publication number
JP2021515789A5
JP2021515789A5 JP2020548696A JP2020548696A JP2021515789A5 JP 2021515789 A5 JP2021515789 A5 JP 2021515789A5 JP 2020548696 A JP2020548696 A JP 2020548696A JP 2020548696 A JP2020548696 A JP 2020548696A JP 2021515789 A5 JP2021515789 A5 JP 2021515789A5
Authority
JP
Japan
Prior art keywords
treatment system
activator
silicone
transdermal treatment
acrylic hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2020548696A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/056016 external-priority patent/WO2019175101A1/en
Publication of JP2021515789A publication Critical patent/JP2021515789A/ja
Publication of JP2021515789A5 publication Critical patent/JP2021515789A5/ja
Abandoned legal-status Critical Current

Links

JP2020548696A 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム Abandoned JP2021515789A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18161432.2 2018-03-13
EP18161432 2018-03-13
PCT/EP2019/056016 WO2019175101A1 (en) 2018-03-13 2019-03-11 Transdermal therapeutic system comprising a silicone acrylic hybrid polymer

Publications (2)

Publication Number Publication Date
JP2021515789A JP2021515789A (ja) 2021-06-24
JP2021515789A5 true JP2021515789A5 (cg-RX-API-DMAC7.html) 2022-03-22

Family

ID=61628186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020548696A Abandoned JP2021515789A (ja) 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム

Country Status (7)

Country Link
US (1) US20210000756A1 (cg-RX-API-DMAC7.html)
EP (1) EP3764996A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021515789A (cg-RX-API-DMAC7.html)
CN (1) CN111867569A (cg-RX-API-DMAC7.html)
BR (1) BR112020018607A2 (cg-RX-API-DMAC7.html)
CA (1) CA3092775A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019175101A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3079694A1 (en) 2017-10-11 2019-04-18 Dow Silicones Corporation Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone acrylic hybrid polymer
BR112020007011A2 (pt) 2017-10-11 2020-10-06 Lts Lohmann Therapie-Systeme Ag sistema terapêutico transdérmico para a administração transdérmica de guanfacina compreendendo pelo menos um aditivo

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6974588B1 (en) * 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
KR101432698B1 (ko) 2006-06-06 2014-08-22 다우 코닝 코포레이션 실리콘 아크릴레이트 하이브리드 조성물
RU2544702C2 (ru) * 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
JP2013139554A (ja) * 2011-11-29 2013-07-18 Dow Corning Corp シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
EA201491164A1 (ru) 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
AU2013205080B2 (en) * 2012-12-12 2016-07-07 Lts Lohmann Therapie-Systeme Ag Transdermal Delivery System
KR102048682B1 (ko) 2015-02-09 2019-11-27 다우 실리콘즈 코포레이션 다중상 실리콘 아크릴 하이브리드 점탄성 조성물 및 이의 제조 방법
US20170112781A1 (en) * 2015-10-27 2017-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems with polyisobutylene face adhesive
WO2018015424A1 (en) * 2016-07-22 2018-01-25 Lts Lohmann Therapie-Systeme Ag Control of adhesive domains

Similar Documents

Publication Publication Date Title
AU2016215180B2 (en) Pressure-sensitive adhesives for transdermal drug delivery
JPH0474329B2 (cg-RX-API-DMAC7.html)
WO2014062494A1 (en) Compositions and methods for the transdermal delivery of methylphenidate
US5260064A (en) Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
JP2017519837A (ja) 経皮送達システム
JPH0725669B2 (ja) 経皮投与用医薬製剤
JPS60185713A (ja) 経皮吸収性製剤及びその製法
JP2021517572A5 (cg-RX-API-DMAC7.html)
EP0285550A2 (en) A percutaneous-administration-type pharmaceutical preparation of nitroglycerin
JP2021515791A5 (cg-RX-API-DMAC7.html)
JP2024532418A5 (cg-RX-API-DMAC7.html)
JP2021522187A5 (cg-RX-API-DMAC7.html)
CN111867569A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
CN111971032A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
JPS6066759A (ja) 医薬製剤
JP2022554147A5 (cg-RX-API-DMAC7.html)
JP2021517569A5 (cg-RX-API-DMAC7.html)
JP4255536B2 (ja) 新規貼付剤
JP3233705B2 (ja) 貼付剤
JP2697191B2 (ja) 経皮吸収製剤
JPH06239753A (ja) 抗血栓経皮吸収製剤
JPS5835113A (ja) 複合製剤
CN111971033A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
JPS6320410B2 (cg-RX-API-DMAC7.html)
CA2934924C (en) Compositions and methods for transdermal delivery of amphetamine